PT1272500E - Processo para preparar derivados de eritromicina substituidos com alcenilo em 6-o - Google Patents

Processo para preparar derivados de eritromicina substituidos com alcenilo em 6-o

Info

Publication number
PT1272500E
PT1272500E PT00942860T PT00942860T PT1272500E PT 1272500 E PT1272500 E PT 1272500E PT 00942860 T PT00942860 T PT 00942860T PT 00942860 T PT00942860 T PT 00942860T PT 1272500 E PT1272500 E PT 1272500E
Authority
PT
Portugal
Prior art keywords
preparing
substituted
alcenyl
derivatives substituted
erythromycine
Prior art date
Application number
PT00942860T
Other languages
English (en)
Inventor
Arthur J Cooper
Anthony R Haight
Yi-Yin Ku
Howard E Morton
Daniel J Plata
Eric J Stoner
Matthew J Peterson
Russell D Cink
Mahendra N Deshpande
Grieme Tim
David R Hill
Hsu Margaret Chi-Ping
Steven A King
Marvin R Leanna
Elaine C Lee
Maureen A Mclaughlin
James J Napier
Prasad S Raje
Rasmussen Michael
Riley David
Jien-Heh J Tien
Steven J Wittenberger
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PT1272500E publication Critical patent/PT1272500E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT00942860T 1999-06-24 2000-06-15 Processo para preparar derivados de eritromicina substituidos com alcenilo em 6-o PT1272500E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14096899P 1999-06-24 1999-06-24

Publications (1)

Publication Number Publication Date
PT1272500E true PT1272500E (pt) 2005-09-30

Family

ID=22493579

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00942860T PT1272500E (pt) 1999-06-24 2000-06-15 Processo para preparar derivados de eritromicina substituidos com alcenilo em 6-o

Country Status (15)

Country Link
US (1) US6437106B1 (pt)
EP (1) EP1272500B1 (pt)
JP (1) JP4795589B2 (pt)
KR (1) KR100696089B1 (pt)
CN (1) CN1216064C (pt)
AT (1) ATE294809T1 (pt)
AU (1) AU779219B2 (pt)
CA (1) CA2375364C (pt)
DE (1) DE60019976T2 (pt)
ES (1) ES2241619T3 (pt)
HK (1) HK1053659A1 (pt)
IL (1) IL147041A0 (pt)
MX (1) MXPA01013396A (pt)
PT (1) PT1272500E (pt)
WO (1) WO2000078773A2 (pt)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives
TWI225067B (en) 2000-08-14 2004-12-11 Taisho Pharmaceutical Co Ltd Processes for preparing erythromycin derivatives
TWI246515B (en) 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
CA2443206A1 (en) 2003-09-23 2005-03-23 Ignis Innovation Inc. Amoled display backplanes - pixel driver circuits, array architecture, and external compensation
US7414030B2 (en) 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
CA2472671A1 (en) 2004-06-29 2005-12-29 Ignis Innovation Inc. Voltage-programming scheme for current-driven amoled displays
US7229972B2 (en) 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
US7419962B2 (en) 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
WO2006065721A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
TW200635600A (en) 2004-12-13 2006-10-16 Enanta Pharm Inc Tetracyclic bicyclolides
US8599191B2 (en) 2011-05-20 2013-12-03 Ignis Innovation Inc. System and methods for extraction of threshold and mobility parameters in AMOLED displays
US9275579B2 (en) 2004-12-15 2016-03-01 Ignis Innovation Inc. System and methods for extraction of threshold and mobility parameters in AMOLED displays
US9171500B2 (en) 2011-05-20 2015-10-27 Ignis Innovation Inc. System and methods for extraction of parasitic parameters in AMOLED displays
US9280933B2 (en) 2004-12-15 2016-03-08 Ignis Innovation Inc. System and methods for extraction of threshold and mobility parameters in AMOLED displays
US9799246B2 (en) 2011-05-20 2017-10-24 Ignis Innovation Inc. System and methods for extraction of threshold and mobility parameters in AMOLED displays
WO2006063448A1 (en) 2004-12-15 2006-06-22 Ignis Innovation Inc. Method and system for programming, calibrating and driving a light emitting device display
US10012678B2 (en) 2004-12-15 2018-07-03 Ignis Innovation Inc. Method and system for programming, calibrating and/or compensating, and driving an LED display
US20140111567A1 (en) 2005-04-12 2014-04-24 Ignis Innovation Inc. System and method for compensation of non-uniformities in light emitting device displays
US8576217B2 (en) 2011-05-20 2013-11-05 Ignis Innovation Inc. System and methods for extraction of threshold and mobility parameters in AMOLED displays
US10013907B2 (en) 2004-12-15 2018-07-03 Ignis Innovation Inc. Method and system for programming, calibrating and/or compensating, and driving an LED display
CA2496642A1 (en) 2005-02-10 2006-08-10 Ignis Innovation Inc. Fast settling time driving method for organic light-emitting diode (oled) displays based on current programming
CN101146815A (zh) * 2005-03-23 2008-03-19 因-斯韦特实验室有限公司 一种制备6-o-甲基红霉素a衍生物的方法
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
CN102663977B (zh) 2005-06-08 2015-11-18 伊格尼斯创新有限公司 用于驱动发光器件显示器的方法和系统
WO2007036951A2 (en) * 2005-08-31 2007-04-05 Alembic Limited Process to obtain 6-o-methylerythromycin a (clarithromycin)_form ii
CA2518276A1 (en) 2005-09-13 2007-03-13 Ignis Innovation Inc. Compensation technique for luminance degradation in electro-luminance devices
US7595300B2 (en) * 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
US7407942B2 (en) 2006-03-29 2008-08-05 Emata Pharmaceuticals, Inc 3,6-bridged 9,12-oxolides
JP5397219B2 (ja) 2006-04-19 2014-01-22 イグニス・イノベーション・インコーポレイテッド アクティブマトリックス表示装置用の安定な駆動スキーム
CN100577678C (zh) * 2006-06-19 2010-01-06 中国医学科学院药物研究所 大环内酯类药物双侧链红霉素a衍生物、合成方法和用途
CA2556961A1 (en) 2006-08-15 2008-02-15 Ignis Innovation Inc. Oled compensation technique based on oled capacitance
EP2214484A4 (en) * 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
US8796232B2 (en) * 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CA2688870A1 (en) 2009-11-30 2011-05-30 Ignis Innovation Inc. Methode and techniques for improving display uniformity
US9384698B2 (en) 2009-11-30 2016-07-05 Ignis Innovation Inc. System and methods for aging compensation in AMOLED displays
US10319307B2 (en) 2009-06-16 2019-06-11 Ignis Innovation Inc. Display system with compensation techniques and/or shared level resources
CA2669367A1 (en) 2009-06-16 2010-12-16 Ignis Innovation Inc Compensation technique for color shift in displays
US9311859B2 (en) 2009-11-30 2016-04-12 Ignis Innovation Inc. Resetting cycle for aging compensation in AMOLED displays
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
US10996258B2 (en) 2009-11-30 2021-05-04 Ignis Innovation Inc. Defect detection and correction of pixel circuits for AMOLED displays
US8803417B2 (en) 2009-12-01 2014-08-12 Ignis Innovation Inc. High resolution pixel architecture
CA2687631A1 (en) 2009-12-06 2011-06-06 Ignis Innovation Inc Low power driving scheme for display applications
US10176736B2 (en) 2010-02-04 2019-01-08 Ignis Innovation Inc. System and methods for extracting correlation curves for an organic light emitting device
US20140313111A1 (en) 2010-02-04 2014-10-23 Ignis Innovation Inc. System and methods for extracting correlation curves for an organic light emitting device
US10163401B2 (en) 2010-02-04 2018-12-25 Ignis Innovation Inc. System and methods for extracting correlation curves for an organic light emitting device
CA2692097A1 (en) 2010-02-04 2011-08-04 Ignis Innovation Inc. Extracting correlation curves for light emitting device
US9881532B2 (en) 2010-02-04 2018-01-30 Ignis Innovation Inc. System and method for extracting correlation curves for an organic light emitting device
US10089921B2 (en) 2010-02-04 2018-10-02 Ignis Innovation Inc. System and methods for extracting correlation curves for an organic light emitting device
CA2696778A1 (en) 2010-03-17 2011-09-17 Ignis Innovation Inc. Lifetime, uniformity, parameter extraction methods
CN103080122A (zh) 2010-03-22 2013-05-01 森普拉制药公司 大环内脂的结晶形式及其用途
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
US8907991B2 (en) 2010-12-02 2014-12-09 Ignis Innovation Inc. System and methods for thermal compensation in AMOLED displays
CN102766089A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 3-(3-喹啉基)-2-丙烯-1-卤代物及其制备方法
CN102766181A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 6-o-取代的红霉素衍生物的制备方法
US9530349B2 (en) 2011-05-20 2016-12-27 Ignis Innovations Inc. Charged-based compensation and parameter extraction in AMOLED displays
US9466240B2 (en) 2011-05-26 2016-10-11 Ignis Innovation Inc. Adaptive feedback system for compensating for aging pixel areas with enhanced estimation speed
EP2715710B1 (en) 2011-05-27 2017-10-18 Ignis Innovation Inc. Systems and methods for aging compensation in amoled displays
US9324268B2 (en) 2013-03-15 2016-04-26 Ignis Innovation Inc. Amoled displays with multiple readout circuits
US10089924B2 (en) 2011-11-29 2018-10-02 Ignis Innovation Inc. Structural and low-frequency non-uniformity compensation
US8937632B2 (en) 2012-02-03 2015-01-20 Ignis Innovation Inc. Driving system for active-matrix displays
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
US9747834B2 (en) 2012-05-11 2017-08-29 Ignis Innovation Inc. Pixel circuits including feedback capacitors and reset capacitors, and display systems therefore
US8922544B2 (en) 2012-05-23 2014-12-30 Ignis Innovation Inc. Display systems with compensation for line propagation delay
US9786223B2 (en) 2012-12-11 2017-10-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
US9336717B2 (en) 2012-12-11 2016-05-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
CN108665836B (zh) 2013-01-14 2021-09-03 伊格尼斯创新公司 补偿测量的器件电流相对于参考电流的偏差的方法和系统
US9830857B2 (en) 2013-01-14 2017-11-28 Ignis Innovation Inc. Cleaning common unwanted signals from pixel measurements in emissive displays
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
EP2779147B1 (en) 2013-03-14 2016-03-02 Ignis Innovation Inc. Re-interpolation with edge detection for extracting an aging pattern for AMOLED displays
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
WO2014174427A1 (en) 2013-04-22 2014-10-30 Ignis Innovation Inc. Inspection system for oled display panels
CN105474296B (zh) 2013-08-12 2017-08-18 伊格尼斯创新公司 一种使用图像数据来驱动显示器的方法及装置
US9761170B2 (en) 2013-12-06 2017-09-12 Ignis Innovation Inc. Correction for localized phenomena in an image array
US9741282B2 (en) 2013-12-06 2017-08-22 Ignis Innovation Inc. OLED display system and method
US9502653B2 (en) 2013-12-25 2016-11-22 Ignis Innovation Inc. Electrode contacts
DE102015206281A1 (de) 2014-04-08 2015-10-08 Ignis Innovation Inc. Anzeigesystem mit gemeinsam genutzten Niveauressourcen für tragbare Vorrichtungen
CA2879462A1 (en) 2015-01-23 2016-07-23 Ignis Innovation Inc. Compensation for color variation in emissive devices
CA2889870A1 (en) 2015-05-04 2016-11-04 Ignis Innovation Inc. Optical feedback system
CA2892714A1 (en) 2015-05-27 2016-11-27 Ignis Innovation Inc Memory bandwidth reduction in compensation system
CA2900170A1 (en) 2015-08-07 2017-02-07 Gholamreza Chaji Calibration of pixel based on improved reference values

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA695765B (en) 1968-08-29 1971-03-31 Lilly Co Eli Erythromycylamine and process for preparing same
GB1344629A (en) 1970-09-30 1974-01-23 Lilly Industries Ltd Erythromycin azine derivatives
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
EP0260938B1 (en) 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin a derivatives and method for preparing the same
KR960000434B1 (ko) 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2751385B2 (ja) 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5719272A (en) 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5837829A (en) 1996-04-02 1998-11-17 Abbott Laboratories 9-oximesilyl erythromycin a derivatives
US5808017A (en) 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
EP1007530B1 (en) 1996-05-07 2005-11-16 Abbott Laboratories 6-o-substituted erythromycin compounds and method for making same
KR100523679B1 (ko) 1996-09-04 2005-10-26 아보트 러보러터리즈 항균 활성을 지닌 6-ｏ-치환된 케톨라이드
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5864023A (en) 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US6610728B2 (en) * 1997-08-28 2003-08-26 Eli Lilly And Company Method for treatment of non-rheumatoid arthritis
ZA987689B (en) 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
US5929219A (en) 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
IL134608A0 (en) 1997-09-30 2001-04-30 Abbott Lab 3'-n- modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
CO4990972A1 (es) 1997-10-29 2000-12-26 Abbott Lab Derivados de eritromicina en puente 6,11
US5852180A (en) 1997-11-17 1998-12-22 Abbott Laboratories Chemical synthesis of 6-O-alkyl erythromycin A
US5892008A (en) 1997-12-16 1999-04-06 Abbott Laboratories Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives

Also Published As

Publication number Publication date
DE60019976D1 (de) 2005-06-09
WO2000078773A2 (en) 2000-12-28
ATE294809T1 (de) 2005-05-15
JP2003502432A (ja) 2003-01-21
CA2375364C (en) 2008-11-25
AU5742900A (en) 2001-01-09
EP1272500A2 (en) 2003-01-08
JP4795589B2 (ja) 2011-10-19
CA2375364A1 (en) 2000-12-28
KR20020033644A (ko) 2002-05-07
DE60019976T2 (de) 2006-02-16
US6437106B1 (en) 2002-08-20
CN1216064C (zh) 2005-08-24
MXPA01013396A (es) 2002-07-30
KR100696089B1 (ko) 2007-03-20
AU779219B2 (en) 2005-01-13
CN1379780A (zh) 2002-11-13
IL147041A0 (en) 2002-08-14
ES2241619T3 (es) 2005-11-01
EP1272500B1 (en) 2005-05-04
HK1053659A1 (en) 2003-10-31
WO2000078773A3 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
PT1272500E (pt) Processo para preparar derivados de eritromicina substituidos com alcenilo em 6-o
DE69910791D1 (de) Abgaskatalysator enthaltend rhodium, zirkon-, cer- und lanthanoxid
BR9909313B1 (pt) Sistema terapêutico transdérmico, processo para a preparação de um sistema terapêutico transdérmico, e, produto
DK0676409T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
BR9812586B1 (pt) sistema de diagnàstico para utilizaÇço em uma rede de controle de processo, e, processo para realizaÇço de diagnàsticos em uma rede de controle de processo.
KR970707179A (ko) 지지된 촉매 시스템의 제조방법 및 이로부터 제조된 촉매 시스템(method for making supported catalyst systems, and catalyst systems therefrom)
DE69918427D1 (de) Rückhaltesystem für schaufelblattfragmente
BR9900307B1 (pt) eletrodo de difusão de gás, célula eletroquìmica e processo para a preparação de catalisador de ródio metálico-óxido de ródio.
BR9604788B1 (pt) dispersço tensoativa formadora de espuma aquosa e estÁvel, e, processo para preparar a mesma.
HUP0104035A2 (hu) Új eritromicinszármazékok, eljárás előállításukra és gyógyszerként való alkalmazásuk
ATE263181T1 (de) Chemische synthese von 6-o-alkyl erythromycin a
DE69916568D1 (de) Pneumatisches Hochgeschwindigkeits-Eingabesystem für Dokumente
TR200201382T2 (tr) Klaritromisin hazırlama yöntemi.
ATE287410T1 (de) Kristalline macrolide und verfahren zu ihrer herstellung
BR9902944B1 (pt) pano tecido nço-revestido para airbags, e seu processo e sistema de produÇço.
NO960495D0 (no) Organoaluminoksy-produkt, katalysatorsystemer, fremgangsmåte for fremstilling
BR0206106A (pt) Método de arilação para a funcionalização de derivados o-alil eritromicina
BR8802783A (pt) Processo para reducao seletiva de oxidos-4 de quinoxalina-2 e processo para preparacao de cloro-6-hidroxiquinoleina-2
BR9610796A (pt) Processo e sistema para produzir serviços de aplicação específica controlados por computador
BR9612064A (pt) Processo para preparação de esteróides 9,11-beta-epóxido
SG71199A1 (en) Process for recovering rhodium catalyst
PT937094E (pt) Processo para a preparacao de ivermectina
DE69918426D1 (de) Buskontaktsystem für hohe geschwindigkeiten
HUP0103997A2 (hu) 6-Dezoxi-eritromicin-származékok, eljárás a vegyületek előállítására és a vegyületek gyógyszerként történő alkalmazása
BR9802373A (pt) Processo para preparar o ácido 3,3-dimetilbutírico